An innovative approach to treating chronic migraine is gaining attention in Charlotte and beyond — and physicians connected to Carolina Pain Institute are helping lead the charge.
A recent article in The Charlotte Post detailed a national clinical study evaluating a novel medical device designed to reduce the frequency and severity of chronic migraines, the most debilitating form of headache disorder. Chronic migraine affects millions nationwide and is defined by 15 or more headache days per month — a life-altering burden for many patients. (The Charlotte Post)
What the Research Shows
The experimental therapy involves a small implant placed just under the skin of the scalp that gently stimulates nerves linked to migraine pain. Early results suggest this neuromodulation technique can cut monthly migraine days in half, offering meaningful relief for patients who haven’t responded to standard medical management. (The Charlotte Post)
Dr. Leo Kapural of Queen City Clinical Research — one of the study’s lead investigators — explained that while the research is still ongoing, this approach represents a promising shift in how severe migraines might be treated in the future. The Food and Drug Administration is overseeing the trial and will evaluate the therapy’s safety and effectiveness as results continue to accrue. (The Charlotte Post)
Chronic Migraine: A Local and National Challenge
Migraines aren’t just “bad headaches.” They often involve intense, throbbing pain accompanied by nausea, visual disturbances, and sensory sensitivity — symptoms that can make daily life difficult or even impossible for sufferers. Current preventive treatments don’t work for everyone, leaving many patients searching for new options. (The Charlotte Post)
The clinical trial behind this emerging therapy, registered as a multicenter, randomized, sham-controlled study, aims to test whether neuromodulation can meaningfully reduce headache days compared with a control intervention. (ClinicalTrials.gov)
Why It Matters to CPI Patients
Carolina Pain Institute is proud to support advancements like this — especially as local experts such as Dr. Chris Gilmore recently discussed similar migraine research on the CAROLINA Focus podcast with WBT. These conversations help bring national innovation to regional patients who are seeking relief.
For people living with chronic migraine in Charlotte and surrounding communities, studies like this represent hope for future therapies that go beyond medications and injections to deliver sustained relief. (The Charlotte Post)
Get Involved or Learn More
If you’re living with chronic migraine and interested in cutting-edge clinical trials or want to learn more about advanced treatment options, contact Carolina Pain Institute to explore your options. Our team stays active in research and patient care to bring the most promising therapies within reach.